You can now read 10 articles in a month for free on BostonGlobe.com. Read as much as you want anywhere and anytime for just 99¢.

The Boston Globe

Business

New Ironwood drug for irritable bowel syndrome with constipation is now available in the US

Ironwood Pharmaceuticals Inc., of Cambridge, and Forest Laboratories Inc. said Monday that Ironwood’s new drug for irritable bowel syndrome with constipation is now available in the United States.

The drug is being marketed in the United States under the brand name Linzess. It was approved by the Food and Drug Administration earlier this year as a treatment for adults suffering from irritable bowel syndrome with constipation. Linzess is a trade name for linaclotide.

Continue reading below

It has been estimated that irritable bowel syndrome afflicts 30 million to 40 million Americans. Some stock analysts project that the Ironwood drug could attain blockbuster status — ringing up sales of more than $1 billion a year worldwide — within a decade, a recent Globe story noted.

Chris Reidy can be reached at reidy@globe.com.

You have reached the limit of 10 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week